- NimbleGen Systems
, a manufacturer of gene chips for pharmaceutical research, will discontinue its work toward an initial public offering of stock following its acquisition by Roche
, the Basel, Switzerland based pharmaceutical giant.
NimbleGen had sought to raise $75 million in the IPO, but und......Full article >>>
ich reported $13.5 million in revenue last year, was spun out of the University of Wisconsin-Madison
and has reached this point with the help of venture funding from firms like Baird Venture Partners
and Venture Investors
. The company pursued an IPO in pa......Full article >>>
potential drug targets.
In addition, NimbleGen plans to expand its product portfolio to include higher-density arrays and integrated instrument systems for advanced genome analysis.
In 2006, the Roche pharmaceuticals division reported sales of 33.3 billion Swiss francs, and the diagnostics division posted sales of 8.7 billion Swiss francs. The com......Full article >>>
xciting" development for the state's biotechnology industry, noting that state officials have been trying to attract a global pharmaceutical company.
Leonhart cited the state's courting of Abbott Labs
, which has acquired 500 acres of land in the Kenosha County communities of Pleasant Prairie and Bristol, but has yet to officially announce whether i......Full article >>>
Source:wistechnology.com By Joe Vanden Plas 06/19/07Related biology technology :1
. NimbleGen researcher to lead $415K DNA project2
. IPO-bound NimbleGen traveling in fast company3
. Madison biotech NimbleGen files for IPO; one of states best-funded firms4
. Genomics researcher Hood joins NimbleGen board5
. NimbleGen partners with UK biotech firm6
. NimbleGen extends research market reach7
. NimbleGen microarrays speed genetic findings8
. NimbleGen names CFO with capital-raising past9
. NimbleGen partners with leading researchers10
. NimbleGen closes $8.2m venture round, bringing total to $50m11
. NimbleGen Systems CGS technique helps identify stomach bacteria